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INTRODUCTION
Vitamin A deficiency (VAD) is a major public health issue in the developing world due to inadequate intake of both preformed vitamin A and provitamin A carotenoids in the diet (1) .
However, detection of subclinical deficiency is problematic since ~85% of vitamin A is stored in the liver while the level of vitamin A circulating in the blood is under strict homeostatic control and not indicative of hepatic reserves (2) . Increasing the intake of provitamin A carotenoids, primarily through β-carotene, is seen as a safe way of restoring vitamin A reserves of an individual since high doses of preformed vitamin A have adverse health effects (3) . Although the current vitamin A equivalency ratio for β-carotene is estimated at 12:1 (by weight) (4), large inter-individual variations in both absorption and conversion have been observed (5) (6) (7) (8) .
In the intestinal mucosa, a proportion of absorbed β-carotene undergoes centric cleavage by the β-carotene 15,15' monooxygenase (BCMO1) enzyme to produce 2 molecules of retinal which are further reduced to retinol (vitamin A) (9) . For export into the circulation, retinol is esterified to a long chain fatty acid, typically palmitate, and incorporated, along with intact β-carotene, into chylomicrons (10) . Subsequently, retinyl esters are either stored in hepatic stellate cells or hydrolysed back to retinol, by the liver, for repartition to other tissue compartments bound to retinol-binding protein (RBP).
Currently, stable isotopes dilution offers the most accurate determination of β-carotene bioefficacy and vitamin A status irrespective of high endogenous circulating levels of these micronutrients (1, 2) . However, the minimum dose to be administered has been dictated by the detection limit of the analytical method (2) . Furthermore, isolation of carotenoids/retinoids from the plasma matrix for MS analysis often involves extensive and time-consuming extraction/purification procedures that have included: saponification, solid-phase extraction (SPE), preparative HPLC and, in the case of GCMS analysis, further conversion to tert-butyl-dimethylsilyl derivatives (11) (12) (13) (14) (15) (16) (17) (18) . The aim was to develop an analytical method that involved a simplified extraction procedure, sensitive MS/MS for detection of physiological doses of stable isotopes, and short LC runtimes so as to be suitable for high-throughput of samples from human intervention studies.
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MATERIALS AND METHODS
Chemicals.
The following carotenoid and retinoid (>95% all-trans) standards were purchased from Sigma (St.
Louis, MO, USA): β-carotene, lycopene, retinol, retinyl acetate, retinyl palmitate. The [12, 12', 13, 13', 14, 14', 15, 15', 20, 20 '- 13 C 10 ]-β-carotene, [8, 9, 10, 11, 12, 13, 14, 15, 19, C 10 ]-retinyl acetate ( Figure 1 ), to be administered to human subjects, were custom synthesised by Buchem BV (Apeldoorn, The Netherlands) and certified fit for human consumption. Similarly, the [8, 8', 9, 9 (Table 2) .
LC/MS/MS validation.
The [ 12 C] species of β-carotene, retinol and retinyl palmitate were used to assess linear dynamic ranges, limits of detection (LOD), limits of quantitation (LOQ), intra-/inter-day assay precision, and to construct external calibration curves. Stock solutions of β-carotene and retinyl palmitate were prepared in chloroform containing 0.1% BHT at respective concentrations of 0.2 mg ml -1 and 1.0 mg ml -1 . Retinol was dissolved in ethanol, containing 0.1% BHT, at 1.0 mg ml -1 . Stock solutions were diluted in ethanol for spectrophotometric determination of absolute concentration at λ max 450nm for β-carotene and 325nm for retinol and retinyl palmitate. Concentrations were calculated from published extinction coefficients (E 1% 1cm ) for these compounds in ethanol (20, 21) . A standard mix of analytes was prepared in ethanol to study linear dynamic range, via serial dilution (11 µM - Table 1 ). The abundant Q3 product ion for retinoids was due to cleavage at the C 9 -C 10 double bond where the selected polyene chain fragment contained all [ Both trans-and cis-β-carotene isomers produced the same Q3 product ions (Supplemental Fig.I ).
Optimised MS/MS parameters and SRM transitions for all analytes are given in Table 1 .
Retinol and retinyl acetate were separated to baseline on a C 18 reversed-phase column with a 1 min linear gradient of 80% to 99% methanol/isopropanol (50:50, w/w); their respective retention times were 0.63 and 0.91 min (Figure 4 ). Retinyl palmitate and β-carotene eluted at 2.36 min and 2.96 min respectively under isocratic conditions of 99% methanol/isopropanol. From extracted control plasma, 2 additional peaks were observed at m/z 269→93 that flanked the retinyl palmitate peak. As these peaks were suspected to be alternative fatty acid esters of retinol, it was necessary to synthesize non-commercially available retinyl esters. The presence of the postulated retinyl esters was confirmed through the use of natural abundance 13 C NMR measured in CDCl 3 using a Jeol ECS-400 MHz. 13 Table 2 . Limits of detection ranged from 10 fmol for retinol to 50 fmol for β-carotene. Linear dynamic ranges were over 2-3 orders of magnitude with r 2 values of >0.999 (Supplemental Fig.II) .
Intra-and inter-day precision ranged from 3.7-3.8 % RSD and 6.5-7.8% RSD respectively. 
DISCUSSION
In human intervention studies, the size of stable isotope dose given is largely determined by the limit of detection of the analytical method (1,2). Although carotene absorption and metabolism may be tracked by the very sensitive method of accelerator mass spectrometry (AMS) (22, 23) , this method involves the administration of radiolabelled material, albeit at micro-doses, and requires laborious sample fractionation to distinguish metabolites, followed by very expensive analysis using highly specialised equipment that is not widely available. Even if other MS methods such as gas chromatography/combustion/isotope-ratio (GC/C/IRMS) and electron capture negative fmol (28) and 57 fmol (27) for β-carotene in previous methods.
The single solvent extraction procedure developed here for both carotenoids and retinoids negated the effect of interfering plasma lipids (31), without saponification, leaving retinyl esters intact.
Consequently, it was not necessary to prepare triglyceride-rich lipoprotein (TRL) fractions to discriminate newly-absorbed intestinally-derived retinyl esters from retinol secreted by the liver bound to retinol binding protein (RBP). However, it is recognised that small amounts (~3%) of unesterified retinol, derived from administered retinyl acetate and β-carotene, may be present in lymph chylomicrons (32,33). Although TRL fractions, obtained by ultracentrifugation at a solution density of <1.006 g ml -1 , contain >83% of retinyl esters in the first 6 hour postprandial period, a large percentage of plasma retinyl esters is progressively and irreversibly transferred to the denser LDL fraction resulting in 32% of the plasma retinyl esters localised to the LDL fraction 12 hours after fat load (34). This transfer of retinyl esters is even more substantial in subjects with familial hypercholesterolemia (35). Furthermore, inter-individual variation in chylomicron clearance kinetics, such as delayed chylomicron remnant clearance in subjects with endogenous hypertriglyceridemia (36), or variation in chylomicron recovery during TRL preparation and analysis reduces the accuracy of this approach to directly measure the mass of retinyl esters or β-carotene absorbed (37) . Thus, the current method can detect intestinally-derived retinyl esters with more accuracy compared to methods employing TRL separations (27,37,38).
The current method also allows β-carotene bioefficacy and vitamin A dilution to be studied concurrently due to differential extrinsic [ 13 between preformed retinol and retinol from provitamin A sources in the enterocyte before incorporation in chylomicrons.
Retinyl acetate was co-administered with β-carotene as a reference dose to correct for inter-and intra-individual variations in intestinal absorption and chylomicron clearance rates (37) . The [ 13 C 10 ]-retinyl acetate dose can also be used to determine total body vitamin A reserves after a sufficient period (circa 3 days) of isotope dilution with endogenous pools (1). In some previous studies, the reference dose was not administered concomitantly with β-carotene to avoid competition during intestinal absorption (12, 14) . Single doses of β-carotene have ranged from 5 to 126 mg due to analytical detection limits dictating the minimum dose that can be administered to human subjects. However, β-carotene bioefficacy is dose-dependent when > 4 mg is ingested (40) , while doses > 6 mg perturb the steady-state equilibrium in the blood (41) . The 2 mg utilised in the current study represents a true physiological dose according to the estimated daily intake of β-carotene in UK and US populations (39) . Although lower doses have been administered daily over a prolonged period to reach a plateau of isotopic enrichment in the blood (15, 16) , multiple dosing cannot establish uptake kinetics.
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In summary, this new sensitive analytical method allows for the simultaneous study of β-carotene bioefficacy and vitamin A status in human subjects at physiological doses for at least 2 weeks. The simple extraction procedure and single 7 min LCMS run-time for all analytes makes the method applicable to the high throughput of samples generated in large human intervention studies. 
